期刊文献+

骨桥蛋白反义基因对胃癌浸润与转移影响的研究 被引量:2

Effect of anti-sense osteopontin on metastasis and infiltration of gastric carcinoma
原文传递
导出
摘要 目的:探讨骨桥蛋白反义基因对人类胃癌细胞增殖和浸润转移的影响。方法:1)PCR扩增获得人OPN基因,pcD-NA3.1(+)载体连接,酶切、测序。2)脂质体介导将pcDNA3.1-ANOPN基因转入ECA109,G418筛选,获得稳定表达AN-OPN基因的转染细胞SGC-7901-ANOPN、表达空载体的SGC-7901-vect细胞和空白对照SGC-7901。RT-PCR检测细胞OPNmRNA表达,体外观察对比各组间倍增时间、黏附、侵袭及迁移能力的差异。结果:成功构建了pcDNA3.1-ANOPN质粒,测序结果与GenBank中公布的序列同源性为100%。与SGC-7901-vect、SGC-7901相比,SGC-7901-ANOPN细胞OPNmRNA表达明显降低,倍增时间增加,黏附、侵袭及迁移能力明显降低。结论:ANOPN基因的稳定表达明显抑制胃癌细胞的恶性表型。 OBJECTIVE:To investigate the effect of anti-sense osteopontin(ANOPN)gene on the proliferation,infiltration and metastasis of gastric carcinoma cells.METHODS:An OPN gene recombinant expression vector plasmid was constructed by RT-PCR from human umbilical vein endothelial cell gene and cloned into a mammalian expression vector pcDNA3.1(+).PcDNA3.1-ANOPN was introduced by Lipofectin to ECA109.Positive cell clones SGC-7901-ANOPN,vector transfected cells SGC-7901-vect and blank cell SGC-7901 were used as three groups.RT-PCR was used to investigate the expressions of OPN mRNA.The metastasis characteristics of the cells were studied by the Transwell method.RESULTS:The vector was constructed successfully,and the sequencing result was 100% identical with that reported in GenBank.Compared with vector-transfected cells SGC-7901-vect cells and SGC-7901 cells,the growth rate of SGC-7901-ANOPN cells was significantly slowed,the expression rate was decreased,their doubling time was increased,and the number of SGC-7901-ANOPN cells in mucosa was decreased.CONCLUSION:The stable expression of ANOPN gene can significantly suppress the malignant phenotype of SGC-7901 cells.
出处 《中华肿瘤防治杂志》 CAS 2010年第5期338-341,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 深圳市龙岗区科技局2009年科研资助项目(2009113)
关键词 骨桥蛋白 胃肿瘤 反义基因 质粒 osteopontin(OPN) stomach neoplasms anti-sense gene plasmid
  • 相关文献

参考文献11

  • 1Chang P L, Cao M, Hicks P. Osteopontin induction is required for tumor promoter induced transformation of preneoplastic mouse cells [J]. Carcinogenesis, 2003, 24(11): 1749-1758.
  • 2Senger D R, Wirth D F, Hynes R O. Transformed mammalian ceils secrete specific proteins and phosphoproteins [J]. Cell, 1979,(16) : 885-893.
  • 3Rittling S R, Chambers A F. Role of osteopontin in tumor progression [J]. BrJ Cancer, 2004,(90):1877-1881.
  • 4Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies [J]. Clin Cancer Res, 2004,10(1):184-190.
  • 5Maeng H Y, Choi D K, Takeuchi M, et al. Appearance of osteopontin expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine [J]. Jpn J Cancer Res, 2002, 93(9): 960- 967.
  • 6Higashiyama M, Ito T, Tanaka E, et aI. Prognostic significance of osteopontin expression in human gastric carcinoma [J]. Ann Surg Oncol, 2007,14(12):3419-3427.
  • 7郝波,张国新,张炜明,施瑞华,王宏娣,赵志泉.骨桥蛋白在人胃癌中的表达及其临床意义[J].中华消化内镜杂志,2005,22(2):111-112. 被引量:9
  • 8孙现军,左文述,马恒,侯文红,蔡淑萍,姜希宏.骨桥蛋白mRNA在胃癌中的表达及其临床意义[J].中华肿瘤杂志,2005,27(5):292-295. 被引量:19
  • 9Ue T, Yokozaki H, Kitadai Y, et al. Coexpression of osteopontin and CD44V9 in gastric cancer [J]. Int J Cancer, 1998, 79 (2) : 127-132.
  • 10Dai N, Bao Q, Lu A, et al. Protein expression of osteopontin in tumor is an independent prognostic indicator in gastric cancer [J]. Oncology, 2007,72(1-2) :89-96.

二级参考文献27

  • 1Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins:Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest,1995,95:713-724.
  • 2Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein(osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA, 1986,83: 8819-8823.
  • 3George NT, Sikes RA, Devoll RE, et al. Osteopontin :possible role in prostate cancer progression. Clin Cancer Res, 1995,5: 2271-2277.
  • 4Weber GF. The metastasis gene osteopontin:a candidate target for cancer therapy. Biochim Biophys Acta,2001,1552: 61-85.
  • 5Coppola D, Szabo M, Boulware D,et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res,2004,10:184-90.
  • 6Ue T , Yokozaki, H, Kitadai, et al. Co-expression of osteopontin and CD44 V9 in gastric cancer. Int J Cancer, 1998,79:127 -132.
  • 7Philip SR, Angela PH, Mohamed ET, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res ,2002,62:3417-3427.
  • 8Kim JH, Skates SJ, Uede T, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. J Am Med Assoc,2002,287:1671-1679.
  • 9Oates A J, Barraelough R, Rudland PS. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis, 1997,17:1-15.
  • 10Rudland PS, Higgins AP, Tanani ME, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res, 2002,62 : 3417-3427.

共引文献25

同被引文献19

  • 1杨晓清,滕良珠.脑膜瘤增殖与复发的分子生物学机制研究进展[J].山东医药,2006,46(30):76-77. 被引量:2
  • 2Shevde LA, Das S, Clark DW, et al. Osteopontin: an effeetor and an effect of tumor metastasis[J]. Curr Mol Meal,2010,10(1): 71-81.
  • 3Kunath T,Gish G, Lickert H, et al. Transgenic RNA interfer- ence in ES cell- derived embryos recapitulates a genetic null phe- notype[J]. Nat Biotechnol,2003,21(5) :559-561.
  • 4Chakravarti A,Palanichamy K. Overcoming therapeutic resistance in malignant gliomas: current practices and future directions[J].Cancer Treat Res,2008,139(2) : 173 -189.
  • 5Rangaswami H, Bulbule A, Kundu GC,et al. Osteopontin: role in cell signaling and cancer progression[J]. Trends Cell Biol, 2006,16(2) :79-87.
  • 6Coppola D,Szabo M,J3oulware D,et al. Correlation of osteopon- tin correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies [J]. Clin Cancer Res,2004,10(1 Pt 1) :184-190.
  • 7Eto M,Kodama S,Nomi N,et al. Clinical significance of elevated osteopontin levels in head and neck cancer patients [J]. Auris Nasus Larynx,2007,34(3) :343-346.
  • 8Le QT, Sutphin PD, Raychaudhun S, et al. Identification of os- teopontin as a prognostic plasma marker for head and neck squa- mous cell carcinomas[J]. Clin Cancer Res, 2003,9(1) : 59-67.
  • 9Celetti A, Testa D,Staibano S, et al. Overexpression of the eyto- kine osteopontin identifies aggressive laryngeal sqnamous cell carcinomas and enhances earcioma cell proliferation and invasive- ness[J]. Clin Cancer Res,2005,11(22) : 8019-8027.
  • 10石海亮,张金丽,焦保华.骨桥蛋白在胶质瘤中的研究进展[J].河北医科大学学报,2009,30(4):415-419. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部